Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
147,179,178
-
Number of holders
-
56
-
Total 13F shares, excl. options
-
60,832,830
-
Shares change
-
+2,941,420
-
Total reported value, excl. options
-
$1,196,651,992
-
Value change
-
+$60,184,105
-
Number of buys
-
42
-
Number of sells
-
21
-
Price
-
$19.69
Institutional Holders of Denali Therapeutics Inc. - COMMON STOCK (DNLI) as of Q1 2018
As of 31 Mar 2018 Denali Therapeutics Inc. - COMMON STOCK (DNLI) had 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 60,832,830 shares of stock of the company.
Largest 10 holders included Crestline Management, LP, FMR LLC, Flagship Pioneering Inc., BAILLIE GIFFORD & CO, Temasek Holdings (Private) Ltd, FIL Ltd, VANGUARD GROUP INC, BlackRock Inc., BAMCO INC /NY/, and Alphabet Inc..
This table shows 72 institutional shareholders of the security as of 31 Mar 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.